| [1] |
潘飞霞, 徐玮泽, 李嘉斌. 中国先天性心脏病疾病负担三十年变化分析[J]. 浙江大学学报(医学版), 2022, 51(3):267-277.
|
| [2] |
马于岚,崔怡然,田刚,等. 中国5岁以下儿童先天性出生缺陷的疾病负担趋势分析[J].中南大学学报(医学版), 2023,48(06):877-886.
|
| [3] |
Zhao Y, Zhang H, Peng M, et al. The burden of congenital birth defects between 1990 and 2019 in China: an observational study[J]. Front Pediatr, 2023, 11:1170755.
|
| [4] |
Chen X, Zhao S, Dong X, et al. Incidence, distribution, disease spectrum, and genetic deficits of congenital heart defects in China: implementation of prenatal ultrasound screening identified 18,171 affected fetuses from 2,452,249 pregnancies[J]. Cell Biosci, 2023, 13(1):229.
|
| [5] |
中国医师协会心血管内科医师分会结构性心脏病学组, 心源性脑卒中人群的高危预测模型及治疗策略的临床研究课题组. 卵圆孔未闭超声诊断中国专家共识[J]. 中国介入心脏病学杂志, 2023, 31(1):4-11.
|
| [6] |
张玉顺, 于生元, 董钊, 等. 卵圆孔未闭相关非卒中性疾病防治中国专家共识[J]. 心脏杂志, 2024, 36(2):125-134.
|
| [7] |
Gaspardone A, Cinque A, Beggio E, et al. Percutaneous suture-mediated patent foramen ovale closure: two-year clinical follow-up[J]. Minerva Cardiol Angiol, 2023, 71(2):169-174.
|
| [8] |
Zannoni J, Popolo Rubbio A, Tusa MB, et al. Mechanisms of ineffective patent foramen ovale closure using the percutaneous suture-mediated NobleStitch system[J]. EuroIntervention, 2022, 18(1):68-70.
|
| [9] |
Beneduce A, Ancona MB, Moroni F, et al. A systematic transoesophageal echocardiography study of suture-mediated percutaneous patent foramen ovale closure[J]. EuroIntervention, 2022, 18(1):63-67.
|
| [10] |
Witte LS, Renkens M, Gąsecka A, et al. Anatomical predictors for suture-based closure of the patent foramen ovale: a multicenter experience[J]. Catheter Cardiovasc Interv, 2023, 102(2):273-280.
|
| [11] |
Scoccia A, Ielasi A, Laricchia A, et al. Percutaneous suture-based closure of patent foramen ovale: initial results of a multi-center experience in a highly selected population[J]. Cardiovasc Revasc Med, 2022, 43:147-149.
|
| [12] |
Gaspardone A, Sgueglia GA, Gaspardone C, et al. A new echocardiographic index to select patients for PFO suture-mediated percutaneous closure[J]. Catheter Cardiovasc Interv, 2023, 101(5):837-846.
|
| [13] |
Yan C, Li H, Wang C, et al. Frequency and size of in situ thrombus within patent foramen ovale[J]. Stroke, 2023, 54(5):1205-1213.
|
| [14] |
Kamran MM, Gopi A, Lakhani Z, et al. Utility of konar-multifunctional occluder in complex situations: unconventional uses in rare situations[J]. Pediatr Cardiol, 2024, 45(1):121-132.
|
| [15] |
王思宝, 泮思林, 罗刚, 等. 经导管肺动脉瓣打孔术治疗新生儿室间隔完整型肺动脉闭锁临床分析[J]. 中华儿科杂志, 2023, 61(2):126-130.
|
| [16] |
焦先婷, 赵莉晴, 沈加, 等. 动脉导管支架置入术治疗不同类型新生儿肺动脉闭锁的随访结局[J]. 中华儿科杂志, 2023, 61(2):136-140.
|
| [17] |
李棣文, 赵天力, 胡世军, 等. 改良Blalock-Taussig分流术与右心室流出道支架植入术姑息性治疗法洛四联症的比较[J]. 中南大学学报(医学版), 2023, 48(9):1325-1332.
|
| [18] |
Guo H, Wu Z, Zhao T, et al. Right ventricular outflow tract stenting promotes pulmonary artery development in tetralogy of fallot[J]. Front Surg, 2023, 10:1056772.
|
| [19] |
李翔, 李晓, 李侨, 等. 介入主动脉支架桥接外科矫治术治疗危重新生儿主动脉缩窄1例[J]. 中国介入心脏病学杂志, 2023, 31(9):714-716.
|
| [20] |
Bjorkman K, Maldonado JR, Saey S, et al. In vitro performance of Lifetech IBS Angel™ (iron-based bioresorbable scaffold) stents during overdilation for use in pediatric patients[J]. Front Cardiovasc Med, 2022, 9:1006063.
|
| [21] |
Mood MC, Niazy KA, Alwi M, et al. Feasibility, safety, and efficacy of iron bioresorbable scaffold in neonates with duct-dependent pulmonary circulation[J]. Ann Pediatr Cardiol, 2022, 15(2):147-153.
|
| [22] |
中国医师协会心血管内科医师分会结构性心脏病学组, 亚洲心脏病学会, 国家放射与治疗临床医学研究中心. 经导管肺动脉瓣置换术亚洲专家共识[J]. 中国介入心脏病学杂志, 2023, 31(6):404-412.
|
| [23] |
Han BK, Garcia S, Aboulhosn J, et al. Technical recommendations for computed tomography guidance of intervention in the right ventricular outflow tract: native RVOT, conduits, and bioprosthetic valves[J]. World J Pediatr Congenit Heart Surg, 2023, 14(6):761-791.
|
| [24] |
Jone PN, Ivy DD, Hauck A, et al. Pulmonary hypertension in congenital heart disease: a scientific statement from the American Heart Association[J]. Circ Heart Fail, 2023, 16(7):e00080.
|
| [25] |
中华医学会小儿外科分会心脏学组, 国家儿童医学中心心血管专科联盟. 儿童先天性心脏病相关性肺高压诊断与治疗指南[J]. 中华小儿外科杂志, 2022, 43(11):966-980.
|
| [26] |
国家心血管病中心肺动脉高压专科联盟国家, 心血管病专家委员会右心与肺血管病专业委员会. 中国肺动脉高压诊治临床路径[J]. 中国循环杂志, 2023, 38(7):691-703.
|
| [27] |
Yang L, Guan L, Chen D, et al. Impact of current targeted drug therapy on the prognosis of Eisenmenger syndrome: a large-scale retrospective analysis[J]. Hellenic J Cardiol, 2023, 72:9-14.
|
| [28] |
Xie F, Quan R, Zhang G, et al. Characteristics, treatments and survival of pulmonary arterial hypertension associated with congenital heart disease in China: Insights from a national multicenter prospective registry[J]. J Heart Lung Transplant, 2023, 42(7):974-984.
|
| [29] |
Haddad RN, Levy M, Szezepanski I, et al. Long-term outcomes of transcatheter Potts shunt in children with suprasystemic pulmonary arterial hypertension[J]. Front Cardiovasc Med, 2022, 9:1028304.
|
| [30] |
Valdeolmillos E, Le Pavec J, Audié M, et al. Thirty years of surgical management of pediatric pulmonary hypertension: mid-term outcomes following reverse Potts shunt and transplantation[J]. J Thorac Cardiovasc Surg, 2023 :S0022-5223(23)01121-01122 [pii].
|
| [31] |
Stephenson N, Pushparajah K, Wheeler G, et al. Extended reality for procedural planning and guidance in structural heart disease - a review of the state-of-the-art[J]. Int J Cardiovasc Imaging, 2023, 39(7):1405-1419.
|
| [32] |
Mahtab E, Egorova AD. Current and future applications of virtual reality technology for cardiac interventions[J]. Nat Rev Cardiol, 2022, 19(12):779-780.
|
| [33] |
Chessa M, Van De Bruaene A, Farooqi K, et al. Three-dimensional printing, holograms, computational modelling, and artificial intelligence for adult congenital heart disease care: an exciting future[J]. Eur Heart J, 2022, 43(28):2672-2684.
|
| [34] |
Iannotta M, d'Aiello FA, Van De Bruaene A, et al. Modern tools in congenital heart disease imaging and procedure planning: a European survey[J]. J Cardiovasc Med (Hagerstown), 2024, 25(1):76-87.
|